Are you Dr. Atassi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 42 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
41 Mall Rd
# Lahey
Boston, MA 01805Phone+1 617-643-0842
Summary
- Dr. Nazem Atassi, MD is a board certified neurologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Massachusetts General Hospital and is an Assistant Professor of Neurology at Massachusetts General Hospital.
Education & Training
Boston University Medical CenterResidency, Neurology, 2004 - 2007- Boston University Medical CenterInternship, Internal Medicine, 2003 - 2004
Damascus University Faculty of MedicineClass of 2002
Certifications & Licensure
MA State Medical License 2008 - 2027- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis Start of enrollment: 2009 Jan 01
- Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2012 Jan 01
- Gilenya in Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2013 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsSafety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants.Agnes Hincelin-Mery, Xavier Nicolas, Cathy Cantalloube, Robert Pomponio, Pascale Lewanczyk
Clinical and Translational Science. 2024-01-01 - 5 citationsAn innovative phase 2 proof-of-concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneu...Luis Querol, Richard A Lewis, Hans-Peter Hartung, Pieter A Van Doorn, Erik Wallstroem
Journal of the Peripheral Nervous System. 2023-06-01 - 24 citationsClassical Complement Pathway Inhibition in a "Human-On-A-Chip" Model of Autoimmune Demyelinating Neuropathies.John W Rumsey, Case Lorance, Max Jackson, Trevor Sasserath, Christopher W McAleer
Advanced Therapeutics. 2022-06-01
Press Mentions
MediciNova Announces Full Enrollment in ALS Biomarker Clinical TrialJuly 29th, 2018
New Imaging Protocol Could Vastly Accelerate Clinical Trials for New ALS TreatmentsMay 31st, 2018- Mass General Investigators on the Cutting Edge of ALS ResearchMay 10th, 2018
- Join now to see all
Professional Memberships
- Member
